Brief: Vyne Therapeutics Completes Enrollment In Phase 2B Trial Evaluating VYN201

YARROW BIOSCIENCE

06/01/2025 12:42

Jan 6 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 2B TRIAL
EVALUATING VYN201 FOR THE TREATMENT OF NONSEGMENTAL VITILIGO
    * VYNE THERAPEUTICS INC - TOP-LINE DATA FROM VYN201 TRIAL
EXPECTED
IN MID-2025

Source text:  urn:newsml:reuters.com:*:nGNX41cC3v
Further company coverage:  VYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))